Company Filing History:
Years Active: 2011
Title: Christiane Juhls: Innovator in Immunotherapy
Introduction
Christiane Juhls is a prominent inventor based in Berlin, Germany. She has made significant contributions to the field of immunotherapy, particularly through her innovative patents. With a total of 2 patents, her work focuses on therapeutic and prophylactic applications that stimulate the immune system in humans and higher animals.
Latest Patents
One of her latest patents is a substituted, non-coding nucleic acid molecule designed for therapeutic and prophylactic stimulation of the immune system. This invention includes short deoxyribonucleic acid molecules that are partially single-stranded, dumbbell-shaped, and covalently closed. These molecules contain one or more unmethylated cytosine guanosine motifs (CpG motifs) and exhibit immunomodifying effects, making them suitable for immunostimulation applications in humans and vertebrates. Another significant patent is a vaccine against oncovirus infections, specifically targeting infections caused by the feline leukosis virus. This vaccine comprises codon-optimized DNA sequences that encode structural proteins and the essential membrane protein of FeLV, providing protection against disease resulting from lentivirus infections.
Career Highlights
Christiane has worked with notable companies such as Mològen AG and Mologen AG. Her experience in these organizations has allowed her to develop and refine her innovative ideas in the field of immunotherapy.
Collaborations
Throughout her career, Christiane has collaborated with talented individuals, including Matthias Schroff and Bernadette Brzezicha. These partnerships have contributed to her success and the advancement of her research.
Conclusion
Christiane Juhls is a remarkable inventor whose work in immunotherapy has the potential to make a significant impact on health and medicine. Her innovative patents reflect her dedication to advancing therapeutic solutions for immune system stimulation.